(บีอี ทีที)

• TETANUS TOXOID (CLOSTRIDIUM TETANI HARVARD STRAIN (49205))>= 40.00 IUต่อ 0.5 ml

ประเภทควบคุม

ยาอันตราย

ข้อบ่งใช้

Tetanus prophylaxis: Adsorbed Tetanus vaccine is indicated for active immunization against tetanus in adults, children and in infants 6 weeks of age or older. Monovalent Adsorbed Tetanus vaccine should not be used in children less than 7 years of age. In children less than 7 years of age, the use of diphtheria, tetanus and pertussis (DTwP) vaccine combination is recommended unless pertussis vaccine is contraindicated. If pertussis is contraindicated then the use of diphtheria and tetanus toxoids (DT) is recommended. , Post exposure prophylaxis of tetanus: Tetanus infection may not confer immunity; therefore initiation or completion of active immunization is indicated at the time of recovery from this infection. , Neonatal tetanus prevention: If vaccination is required, tetanus toxoid can be used during pregnancy. Teratogenic effects have not been reported with tetanus toxoid in humans. Waiting until the second trimester to administer tetanus vaccine is a reasonable precaution for minimizing any concern regarding the theoretical possibility of adverse reactions. , Tetanus Prophylaxis in Wound Management: Tetanus toxoid can also be used prophylactically for wound management in persons 7 years of age and older; tetanus and diphtheria toxoid (Td) is preferred, to maintain adequate levels of diphtheria immunity.

รหัส ATC

J07AM01 (tetanus toxoid)

ข้อมูลตามที่ขึ้นทะเบียนกับ อย. — ไม่ใช่คำแนะนำการใช้ยา ปรึกษาเภสัชกรหรือแพทย์ก่อนใช้เสมอ